Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier Function

NCT04556461 is registered in ClinicalTrials.gov with Prof. Dr. Stephan Weidinger as lead sponsor.

NCT NCT04556461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04556461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier Function
Lead sponsor
Prof. Dr. Stephan Weidinger
Phase
Phase 2
Overall status
Completed
Start date
September 28, 2020
Completion date
March 31, 2023
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis